Nurr1 mutational screen in Parkinson's disease
10.1002/mds.20246
Saved in:
Main Authors: | Tan E.-K., Chung H., Chandran V.R., Tan C., Shen H., Yew K., Pavanni R., Puvan K.-A., Wong M.-C., Teoh M.-L., Yih Y., Zhao Y. |
---|---|
Other Authors: | PHARMACOLOGY |
Format: | Article |
Published: |
Wiley
2018
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/150235 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Genetic analysis of Nurr1 haplotypes in Parkinson's disease
by: Tan E.-K., et al.
Published: (2018) -
Nuclear receptor Nurr1 agonists enhance its dual functions and improve behavioral deficits in an animal model of Parkinson’s disease
by: Kim, Chun-Hyung, et al.
Published: (2015) -
Prostaglandin A2 interacts with Nurr1 and ameliorates behavioral deficits in Parkinson's disease fly model
by: Rajan, Sreekanth, et al.
Published: (2022) -
The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients
by: Tan E.K., et al.
Published: (2018) -
Genetic analysis of DJ-1 in a cohort Parkinson's disease patients of different ethnicity
by: Tan E.-K., et al.
Published: (2018)